Search

everythinglearnresearchcommunity

for

Search:↓

Patients with certain skin symptoms and high ANA titers should be monitored for potential systemic lupus.

Type I interferons play a key role in the development of various skin diseases.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Janus kinase inhibitors are promising drugs for treating autoimmune and inflammatory diseases.

The 308-nm excimer laser is a promising treatment for vitiligo with varying success and mild side effects.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

Anifrolumab effectively improved lupus headaches in a patient unresponsive to other treatments.

Careful monitoring is crucial to prevent JC virus reactivation in lupus patients treated with rituximab.

Anifrolumab helped some lupus patients reduce steroid use, but safety concerns remain.

Living with lupus as both a patient and doctor improved understanding and care for others.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Early diagnosis and treatment are crucial for CAPS, and Eculizumab can be effective.

Middle-aged women with dilated cardiomyopathy should be screened for antiphospholipid syndrome.

Early recognition and a team approach are crucial for managing diffuse alveolar hemorrhage in antiphospholipid syndrome.

Proactive physical therapy improved mobility, reduced fatigue, and pain in lupus patients.

SLE can cause unusual gastrointestinal symptoms, and immunosuppressive therapy can be effective.

Lupus patients in Ghana face healthcare challenges, and the Oyemam Autoimmune Foundation is working to improve awareness and support.

Purpura fulminans can signal underlying autoimmune disorders, not just infections.

Antiphospholipid syndrome can severely damage adrenal glands, requiring early diagnosis and treatment.

Anti-CD19 therapy may help treat SLE and NMOSD.

Catatonia can be a rare sign of lupus, needing careful diagnosis and treatment.

New treatments and understanding of skin lupus are emerging in 2024.

A TNFAIP3 gene mutation can cause unusual and varied symptoms of lupus and Sjogren's syndrome.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

Some plants used in traditional medicine may help treat cancer because they contain proteins that can inactivate ribosomes.

Low serum complement levels in SLE patients don't always match with disease flares; monitoring C3 and C4 is useful, but cell-bound complement products might better indicate disease activity.

Women with Systemic Lupus Erythematosus should have closely monitored pregnancies and avoid certain medications to improve their pregnancy outcomes.

The document explains the difficulty in diagnosing and treating brain diseases caused by the immune system and stresses the need for quick and accurate tests.

The document concludes that anti-dsDNA antibodies are not unique to SLE and their use as indicators is doubtful, highlighting the need for better understanding and classification of the disease.